Therapeutic improvement of CFTR function and reversibility of bronchiectasis in cystic fibrosis
The study by Cazier and co-workers promotes current efforts to diagnose and treat CF lung disease as early as possible in order to prevent structural lung damage, and to target initially reversible changes before persistent airway damage is established
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
14 Feb 2024
|
| In: |
The European respiratory journal
Year: 2024, Jahrgang: 63, Heft: 3, Pages: 2400234-1-2400234-6 |
| ISSN: | 1399-3003 |
| DOI: | 10.1183/13993003.00234-2024 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1183/13993003.00234-2024 Verlag, lizenzpflichtig, Volltext: https://erj.ersjournals.com/content/63/3/2400234 
|
| Verfasserangaben: | Mark O. Wielpütz and Marcus A. Mall |
| Zusammenfassung: | The study by Cazier and co-workers promotes current efforts to diagnose and treat CF lung disease as early as possible in order to prevent structural lung damage, and to target initially reversible changes before persistent airway damage is established |
|---|---|
| Beschreibung: | Gesehen am 18.10.2024 |
| Beschreibung: | Online Resource |
| ISSN: | 1399-3003 |
| DOI: | 10.1183/13993003.00234-2024 |